Latest News
October 26, 2020
Not intended for U.S. and UK Media
Rivaroxaban application submitted to U.S. FDA for new indication in patients after lower-extremity revascularization due to symptomatic PAD
October 26, 2020
Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy
October 23, 2020
Not intended for U.S. and UK Media – Data from Phase III FIDELIO-DKD study presented at the American Society of Nephrology (ASN)’s Kidney Week 2020
Finerenone significantly reduced renal and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes

Find Your Product

With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products.